Growth hormone in adults: indications and implications.
Adults with hypopituitarism and documented growth hormone deficiency are now eligible for replacement therapy. What are the guidelines for diagnosis and treatment? More broadly, what are the implications for other adults with hyposomatotropism-namely, the elderly? And is there a therapeutic role for the hormone in patients with disease states such as osteoporosis, heart failure, and acute catabolic illness?
Inzucchi
S E
SE
Yale University, USA.
D000328:Adult; D000375:Aging / Q000187:drug effects / Q000502:physiology; D009202:Cardiomyopathies / Q000188:drug therapy; D005260:Female; D006130:Growth Disorders / Q000188:drug therapy; D019382:Human Growth Hormone / Q000009:adverse effects / Q000172:deficiency / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000172:deficiency / Q000502:physiology; D008297:Male; D010024:Osteoporosis / Q000188:drug therapy
D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I